Synopsis:
Serum Galectin 3 is a promising diagnostic indicator for some carcinomas. This study estimated the serum Gal-3 in patients with hepatocelluar carcinoma. And learn that the expression of serum Galectin 3 possibility tended to be a bigger biomarker for diagnosis of HCC.